Non-Hodgkin Lymphoma


Adult CCSs report financial hardships

Health-related financial hardship is common among adult survivors of childhood cancer, according to a study published in the Journal of the...


Global burden of hematologic malignancies

Research has shown an increase in the global incidence of leukemia and non-Hodgkin lymphoma (NHL) in recent years. The Global Burden of Disease (...


FDA approves biosimilar filgrastim

The US Food and Drug Administration (FDA) has approved the leukocyte growth factor Nivestym™ (filgrastim-aafi), a biosimilar to Neupogen (...